ketoconazole has been researched along with lenvatinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peiró, I; Simó-Servat, A; Villabona, C | 1 |
| Geng, P; Han, A; Lu, Z; Song, X; Wang, S; Wang, Y; Wu, Q; Xia, M; Zhou, Q; Zhou, Y | 1 |
2 other study(ies) available for ketoconazole and lenvatinib
| Article | Year |
|---|---|
Corticotropin secreting pancreatic neuroendocrine tumour, a therapeutic management challenge. A presentation of 2 cases.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Chromogranins; Combined Modality Therapy; Embolization, Therapeutic; Everolimus; Female; Fludrocortisone; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Peptides, Cyclic; Phenylurea Compounds; Quinolines; Somatostatin; Spironolactone; Splenectomy; Sunitinib | 2019 |
Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC-MS/MS.
Topics: Animals; Antifungal Agents; Azoles; Chromatography, Liquid; Humans; Ketoconazole; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Voriconazole | 2023 |